Litalir
Brand names,
Litalir
Analogs
Litalir
Brand Names Mixture
Litalir
Chemical_Formula
CH4N2O2
Litalir
RX_link
http://www.rxlist.com/cgi/generic2/hydroxyurea.htm
Litalir
fda sheet
Litalir
msds (material safety sheet)
Litalir
Synthesis Reference
No information avaliable
Litalir
Molecular Weight
76.0547 g/mol
Litalir
Melting Point
142-146 oC
Litalir
H2O Solubility
1E+006 mg/L
Litalir
State
Solid
Litalir
LogP
-1.432
Litalir
Dosage Forms
Capsule
Litalir
Indication
For management of melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary and Sickle-cell anemia.
Litalir
Pharmacology
Hydroxyurea has dose-dependent synergistic activity with cisplatin in vitro. In vivo Hydroxyurea showed activity in combination with cisplatin against the LX-1 and CALU-6 human lung xenografts, but minimal activity was seen with the NCI-H460 or NCI-H520 xenografts. Hydroxyurea was synergistic with cisplatin in the Lewis lung murine xenograft. Sequential exposure to Hydroxyurea 4 hours before cisplatin produced the greatest interaction.
Litalir
Absorption
Well absorbed from the gastrointestinal tract.
Litalir
side effects and Toxicity
Oral, mouse: LD50 = 7330 mg/kg; Oral, rat: LD50 = 5760 mg/kg
Litalir
Patient Information
HYDREA is a medication that must be handled with care. People who are not taking HYDREA should not be
exposed to it. If the powder from the capsule is spilled, it should be wiped up immediately with a damp disposable
towel and discarded in a closed container, such as a plastic bag. The medication should be kept away from children
and pets.
Litalir
Organisms Affected
Humans and other mammals